The CLIP1–LTK fusion is an oncogenic driver in non‐small‐cell lung cancer

Description

Department of Thoracic Oncology National Cancer Center Hospital East

Genotype-phenotype mapping of a patient-derived lung cancer organoid biobank identifies NKX2-1-defined Wnt dependency in lung adenocarcinoma - ScienceDirect

The CLIP1-LTK fusion is an oncogenic driver in non-small-cell lung cancer. - Abstract - Europe PMC

Electropherogram showing Sanger sequencing of the CLIP1-LTK fusion

Utility of needle biopsy in centrally located lung cancer for genome analysis: a retrospective cohort study, BMC Pulmonary Medicine

AMG-510 and cisplatin combination increases antitumor effect in lung adenocarcinoma with mutation of KRAS G12C: a preclinical and translational research

Frontiers Recent progress in targeted therapy for non-small cell lung cancer

Oncogenic driver mutations in non-small cell lung cancer: Past, present and future

Immune Checkpoint Blockade in Oncogene-Driven Non-Small-Cell Lung Cancer

$ 16.50USD
Score 4.7(302)
In stock
Continue to book